Hydrochloric Acid

Hydrochloric Acid

SCHEMBL994292

CC(C)CNCCC(=O)c1cccs1.Cl

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 known ✓ Q13547 1/20 0.48
ALDH1A1 P00352 6/20 0.57
LMNA P02545 4/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
POLB P06746 1/20 0.57
HPGD P15428 5/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
GSK3B P49841 1/20 0.50
CTNNB1 P35222 4/20 0.48
WNT3A P56704 3/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
PKM P14618 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
HSD17B10 Q99714 1/20 0.48
ERCC5 P28715 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13518261 0.88 ALDH1A1 (0.57) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL13519106 0.86 ALDH1A1 (0.54) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL13517942 0.85 ALDH1A1 (0.61) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL13518471 0.82 ALDH1A1 (0.53) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL16419608 0.81 ALDH1A1 (0.65) ALDH1A1LMNANPC1RAB9AMEN1
Hydrochloric Acid SCHEMBL992300 0.80 ALDH1A1 (0.67) ALDH1A1LMNANPC1RAB9AMEN1
Hydrochloric Acid SCHEMBL691269 0.79 LMNA (0.57) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL13517704 0.79 TSHR (0.51) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL13519262 0.78 HPGD (0.53) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL170394 0.78 ALDH1A1 (0.69) ALDH1A1LMNANPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170369467-A1 Process for the Preparation of N-Monosubstituted beta-Amino Alcohols LONZA AG (CH) 2017-12-28 US disclosed
US-20150361064-A1 Process for the Preparation of N-Monosubstituted beta-Amino Alcohols LONZA AG (CH) 2015-12-17 US disclosed
US-20150112086-A1 Process for the Preparation of N-Monosubstituted beta-Amino Alcohols LONZA AG (CH) 2015-04-23 US disclosed
US-8962865-B2 Process for the preparation of N-monosubstituted β-amino alcohols LONZA AG (CH) 2015-02-24 US disclosed
US-20130310574-A1 Process for the Preparation of N-Monosubstituted beta-Amino Alcohols LONZA AG (CH) 2013-11-21 US disclosed
US-8558014-B2 Process for the preparation of N-monosubstituted β-amino alcohols LONZA AG (CH) 2013-10-15 US disclosed
US-20110004007-A1 PROCESS FOR THE PREPARATION OF N-MONOSUBSTITUTED beta-AMINO ALCOHOLS LONZA AG (CH) 2011-01-06 US disclosed
US-20100240911-A1 Process for the preparation of N-monosubstituted beta-amino alcohols LONZA AG (CH) 2010-09-23 US disclosed
US-20080119661-A1 Process for the preparation of N-monosubstituted beta-amino alcohols LONZA AG (CH) 2008-05-22 US disclosed
EP-1539673-B1 PROCESS FOR THE PREPARATION OF N -MONOSUBSTITUTED BETA-AMINO ALCOHOLS LONZA AG (CH) 2007-10-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150361064-A1 Process for the Preparation of N-Monosubstituted beta-Amino Alcohols ADH1A, ADH1C, ASNS HDAC1 3530/4885ALDH1A1 106/4885LMNA 1290/4885
US-20150112086-A1 Process for the Preparation of N-Monosubstituted beta-Amino Alcohols ADH1A, ADH1C, ASNS HDAC1 3530/4885ALDH1A1 106/4885LMNA 1290/4885
US-20110004007-A1 PROCESS FOR THE PREPARATION OF N-MONOSUBSTITUTED beta-AMINO ALCOHOLS ADH1C, ADH1A, ADH5 HDAC1 1980/4885ALDH1A1 307/4885LMNA 961/4885
US-20080119661-A1 Process for the preparation of N-monosubstituted beta-amino alcohols ADH1C, ADH1A, HRH2 HDAC1 1690/4885ALDH1A1 379/4885LMNA 993/4885
US-20170369467-A1 Process for the Preparation of N-Monosubstituted beta-Amino Alcohols ADH1A, ADH1C, ASNS HDAC1 3530/4885ALDH1A1 106/4885LMNA 1290/4885
US-20100240911-A1 Process for the preparation of N-monosubstituted beta-amino alcohols ADH1A, ADH1C, H1-0 HDAC1 1688/4885ALDH1A1 83/4885LMNA 440/4885
US-20130310574-A1 Process for the Preparation of N-Monosubstituted beta-Amino Alcohols ADH1A, ADH1C, ASNS HDAC1 3530/4885ALDH1A1 106/4885LMNA 1290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.